Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-29

Clinical Trial Update: Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

View source ↗

Summary

A clinical trial will compare outcomes in immunocompetent versus immunocompromised tuberculosis patients and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sohag University | Conditions: Tuberculosis | Status: NOT_YET_RECRUITING